释放针对癌症治疗的双特异性ADC的潜力
Hongye Zeng1,2, Wenjing Ning1,2, Xue Liu3,4
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Frontiers of medicine
|July 22, 2024
概括
与传统的基于单克隆抗体的ADC相比,双特异性抗体-药物合物 (ADC) 通过增强瘤细胞向和减少副作用,可以改善癌症治疗. 本综述探讨了他们的临床试验状态和未来的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物结合体 (ADCs) 使用抗体将细胞毒药物分泌到瘤细胞,从而最大限度地降低了目标外毒性.
- 基于单克隆抗体的ADC在平衡治疗疗效与患者安全方面面临挑战.
- 双特异性抗体提供了增强的内部化和选择性,在ADC开发方面比单克隆抗体具有优势.
研究的目的:
- 审查癌症治疗中双特异抗体-药物联合体 (ADC) 的现有证据和未来前景.
- 为提供目前正在进行临床试验的双特异性ADCs的全面概述.
- 提供对开发双特异性ADC改进癌症治疗的新策略的见解.
主要方法:
- 关于双特异抗体与药物合物的现有研究的文献综述.
- 对双特异性ADC的临床试验数据的分析.
- 探索双特异性ADCs的未来研究和开发方向.
主要成果:
- 与传统的ADC相比,双特异性ADC显示出更高的内部化和选择性.
- 临床试验表明,对双特异性ADC的安全性和有效性概况有希望.
- 双特异性ADCs的发展代表了向癌症治疗的重大进步.
结论:
- 双特异性ADC具有改善癌症治疗结果的巨大潜力.
- 需要进一步的研究和临床评估,才能充分认识到双特异性ADCs的治疗益处.
- 双特异性ADC为新的癌症治疗策略提供了一个有希望的途径.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501